Skip to content

PATHFINDER CELL THERAPY, INC.

CIK 0000889428

← back to feed
Revenue (TTM)
$54K
−100.0% YoY Q3 Sep 2015
Net Income (TTM)
−$1.07M
+18.2% YoY Q3 Sep 2015
EPS Diluted (TTM)
—
Q3 Sep 2015
Gross Margin
55.6%
Q3 Sep 2015
Operating Margin
-1,425.9%
Q3 Sep 2015
Net Margin
-1,983.3%
Q3 Sep 2015
Free Cash Flow (TTM)
—
Q3 Sep 2015
Cash
$4K
Q3 Sep 2015
Total Debt
$241K
Q3 Sep 2015
Shares Outstanding
667.16M sh
Q3 Sep 2015

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings